Overview
Solid-Phase Peptide Synthesis (SPPS) is the cornerstone of modern peptide manufacturing. Invented by Robert Bruce Merrifield in 1963, the technique involves the stepwise assembly of a peptide chain on an insoluble polymeric support (resin), enabling the use of excess reagents and simple washing steps to drive reactions to completion. At Peptide Labs Health, we employ state-of-the-art Fmoc-based SPPS with automated synthesizers capable of producing peptides ranging from simple dipeptides to complex sequences exceeding 100 amino acid residues.
Our synthesis platform incorporates microwave-assisted coupling for difficult sequences, pseudoproline dipeptide building blocks to disrupt on-resin aggregation, and real-time monitoring of coupling efficiency via colorimetric and spectrophotometric methods. These technologies, combined with rigorous process optimization and quality control, enable us to routinely achieve crude purities of 70-85% for standard sequences and greater than 60% for complex or long peptides, minimizing the purification burden and maximizing overall yield.
Capabilities
Our SPPS platform supports a comprehensive range of modifications, including N-terminal acetylation, C-terminal amidation, disulfide bridge formation, lactam cyclization, PEGylation, fluorescent labeling (FITC, TAMRA, Cy5), biotinylation, and phosphorylation. We maintain an inventory of over 300 Fmoc-protected amino acid building blocks, including non-natural amino acids, D-amino acids, and specialty residues, enabling the synthesis of virtually any peptide sequence with custom modifications to meet your research needs.